TITLE:
Strategizing the Development of Alzheimer’s Therapeutics
AUTHORS:
Justin Davis, Robin Couch
KEYWORDS:
Drug Discovery, Alzheimer’s Disease, Target Identification, Therapeutics, Review
JOURNAL NAME:
Advances in Alzheimer's Disease,
Vol.3 No.3,
September
12,
2014
ABSTRACT: Alzheimer’s Disease is a complex, progressive condition with symptoms that do not reveal themselves until significant changes to neuronal morphology have already occurred. The delayed manifestation of cognitive decline makes determination of the true etiological origins difficult. As a result, identification of ideal drug targets becomes seemingly impossible. The existing treatments for Alzheimer’s Disease may temporarily suppress the rate of cognitive decline, but do little to slow or halt neuronal decay. While many believe that the current approaches to identifying a cure for the disease are too narrow-minded, focusing heavily on the physical manifestations of the diseased brain such as amyloid plaques and neurofibrillary tangles, this review asserts the status of Alzheimer’s research as rational and multi-faceted.